Pakawat Chongsathidkiet, who is a second year PhD student in the Pathology Department, and his colleagues in the Duke Brain Tumor Immunotherapy Program have received good news: their revised manuscript on bone marrow T-cell sequestration in glioblastoma has been accepted for publication by Nature Medicine. Glioblastoma is the most common primary brain tumor in adults with one of the poorest prognoses known to mankind. Nature Medicine is a prestigious journal and we are very proud of Pakawat for the great accomplishment of being published, but more importantly, for the scientific advances his work is making for patients suffering from this disease.
Pakawat, a native of Thailand who came to Duke to pursue training as a physician-scientist, is completing his PhD with a focus on T-cell dysfunction in brain tumors, in the laboratory of Peter Fecci, MD, PhD, the director of Duke Brain Tumor Immunotherapy Program. Dr. Fecci joined the Duke Graduate Faculty in 2014 and is also an alumnus of our Duke Pathology Graduate Program, graduating in 2007. After completion of his PhD degree, Pakawat hopes to continue translational research in the field of neuro-oncology and pursue residency training in neurosurgery.